These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
634 related articles for article (PubMed ID: 29239821)
1. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway. Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821 [TBL] [Abstract][Full Text] [Related]
2. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC). He R; Zhang FH; Shen N Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway. Zhao X; Cheng Z; Wang J Med Sci Monit; 2018 Nov; 24():8088-8095. PubMed ID: 30416194 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2. Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620 [TBL] [Abstract][Full Text] [Related]
6. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer. Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996 [TBL] [Abstract][Full Text] [Related]
7. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer. Feng Y; Zhang Q; Wang J; Liu P Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981 [TBL] [Abstract][Full Text] [Related]
8. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer. Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221 [TBL] [Abstract][Full Text] [Related]
9. LincRNAFEZF1-AS1 represses p21 expression to promote gastric cancer proliferation through LSD1-Mediated H3K4me2 demethylation. Liu YW; Xia R; Lu K; Xie M; Yang F; Sun M; De W; Wang C; Ji G Mol Cancer; 2017 Feb; 16(1):39. PubMed ID: 28209170 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma. Chen N; Guo D; Xu Q; Yang M; Wang D; Peng M; Ding Y; Wang S; Zhou J Oncotarget; 2016 Mar; 7(10):11271-83. PubMed ID: 26848625 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA FEZF1-AS1 in human cancers. Zhou Y; Xu S; Xia H; Gao Z; Huang R; Tang E; Jiang X Clin Chim Acta; 2019 Oct; 497():20-26. PubMed ID: 31276636 [TBL] [Abstract][Full Text] [Related]
12. FEZF1-AS1 is a key regulator of cell cycle, epithelial-mesenchymal transition and Wnt/β-catenin signaling in nasopharyngeal carcinoma cells. Cheng Y Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30355645 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma. Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463 [TBL] [Abstract][Full Text] [Related]
14. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling. Zhou C; An N; Cao C; Wang G J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743 [TBL] [Abstract][Full Text] [Related]
15. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1. Zhao Y; Liu Y; Lin L; Huang Q; He W; Zhang S; Dong S; Wen Z; Rao J; Liao W; Shi M Mol Cancer; 2018 Mar; 17(1):69. PubMed ID: 29510730 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NNT-AS1 sponges miR-424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer. Chen B; Zhao Q; Guan L; Lv H; Bie L; Huang J; Chen XB J Cell Mol Med; 2018 Oct; 22(10):4751-4759. PubMed ID: 30006956 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors. Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939 [TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway. Yang L; Ye Y; Chu J; Jia J; Qu Y; Sun T; Yin H; Ming L; Wan J; He F Cancer Manag Res; 2019; 11():4425-4435. PubMed ID: 31191005 [No Abstract] [Full Text] [Related]
20. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer. Zhang HH; Li AH Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]